MNPR Monopar Therapeutics Inc

-0.0003 (-0.05%)
Last Updated: 13:25:03
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Company Name Stock Ticker Symbol Market Type
Monopar Therapeutics Inc MNPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0003 -0.05% 0.5505 13:25:03
Open Price Low Price High Price Close Price Prev Close
0.5605 0.545 0.57 0.5508
more quote information »

Recent News

Date Time Source Heading
10/04/20239:00IHNWFeaturedUCASU announces plan of stock buyback
10/03/202319:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202319:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202307:00GLOBEMonopar to Participate in the H.C. Wainwright 25th Annual..
8/30/202317:16EDGAR2Form 8-K - Current report
8/10/202307:00EDGAR2Form 8-K - Current report
8/10/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:00GLOBEMonopar Therapeutics Reports Second Quarter 2023 Financial..
8/08/202307:00EDGAR2Form 8-K - Current report
8/08/202307:00GLOBEMonopar Provides Encouraging Camsirubicin Clinical Data..
7/11/202307:00EDGAR2Form 8-K - Current report
7/11/202307:00GLOBEMonopar Announces MNPR-101 Radiopharma Collaboration..
7/03/202318:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/03/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202316:13EDGAR2Form 8-K - Current report
6/21/202307:00GLOBEMonopar to Participate in the Radiopharma Forum by the Lake..
6/14/202307:00GLOBEMonopar to Participate in the Maxim Group’s Healthcare..
6/01/202307:00GLOBEMonopar Announces Encouraging Camsirubicin Phase 1b Trial..
5/11/202307:00GLOBEMonopar Therapeutics Reports First Quarter 2023 Financial..
3/28/202307:00GLOBEMonopar to Present at the Jefferies Radiopharma Innovation..
3/27/202317:00GLOBEMonopar Announces Result of Interim Analysis of Phase 2b/3..
3/23/202307:00GLOBEMonopar Therapeutics Reports Fourth Quarter and Full-Year..
3/07/202307:00GLOBEMonopar to Present at the 35th Annual Roth Conference
2/27/202307:00GLOBEMonopar and NorthStar Announce Expanded Radiopharma Program,..
2/14/202307:00GLOBEMonopar Announces Camsirubicin Clinical Program Update -..
1/26/202307:00GLOBEMonopar Announces Projected Timeline of Upcoming Q1 2023..
1/18/202307:00GLOBEMonopar Announces Successful Advancement of Camsirubicin..
12/12/202207:00GLOBEMonopar Announces Promising MNPR-202 Data from Ongoing..
11/16/202211:15TRMNJonesTrading Remains a Buy on Monopar Therapeutics Inc..
11/16/202207:00GLOBEMonopar Announces Encouraging Clinical Data from Ongoing..
11/11/202210:45TRMNMaxim Group Keeps Their Buy Rating on Monopar Therapeutics..
11/10/202216:25TRMNJonesTrading Reaffirms Their Buy Rating on Monopar..
11/10/202208:00GLOBEMonopar Therapeutics Reports Third Quarter 2022 Financial..
10/27/202208:00GLOBEMonopar Announces Timeline of Upcoming Data Events for..
10/19/202208:00GLOBEMonopar Announces Presentation Selected for 2022 American..
10/12/202208:00GLOBEMonopar Announces Presentation Selected for 2022 Connective..
10/06/202210:55TRMNMaxim Group Sticks to Their Buy Rating for Monopar..
10/05/202208:00GLOBEMonopar Announces Completion of Phase 2b Enrollment and..
Your Recent History
Monopar Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now